To include your compound in the COVID-19 Resource Center, submit it here.

Impact in $90M financing deal with Oberland

The deal includes two $20 million milestone payments to Impact, for which Oberland will receive predefined royalties on fedratinib sales.

Read the full 205 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE